LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-5.75 Cr | ₹-8.32 Cr | ₹-8.14 Cr | ₹4.52 Cr | ₹-3.57 Cr |
What is the latest Cash Flow from Financing Activities ratio of LACTOSE (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-5.75 Cr |
Mar2023 | ₹-8.32 Cr |
Mar2022 | ₹-8.14 Cr |
Mar2021 | ₹4.52 Cr |
Mar2020 | ₹-3.57 Cr |
How is Cash Flow from Financing Activities of LACTOSE (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-5.75 Cr | Negative | |
Mar2023 | ₹-8.32 Cr | Negative | |
Mar2022 | ₹-8.14 Cr | Negative | |
Mar2021 | ₹4.52 Cr | Positive | |
Mar2020 | ₹-3.57 Cr | - |
Compare Cash Flow from Financing Activities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹124.9 Cr | 0.9% | -1.1% | -44.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | 0.9% |
-1.1% |
-44.4% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses